Tech
Millions of Americans are not taking their GLP-1 drugs as prescribed
Publication: Ars Technica
Author: Beth Mole
Source published: 13/11/2026, 21:59:01 UTC
Briefing created: 13/11/2026, 22:46:19 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 13/11/2026, 22:28:23 UTC.
Briefings
A CDC study analyzed 8,000 US adults and found that 9.8% of Americans used GLP-1 medications in 2025, with 44% modifying their usage due to cost or availability. Younger adults (14-39) were more likely to cite cost as a barrier compared to older adults.
Key points
- CDC analyzed survey data from over 8,000 US adults between July and August 2025.
- Approximately 9.8% of adults used GLP-1 medications in 2025, totaling 27 million users.
Context
GLP-1 medications are widely used for diabetes, weight loss, and chronic conditions. This study highlights a significant shift in real-world usage patterns among millions of Americans.
Limitations
Data covers only July-August 2025; findings may not reflect long-term safety or efficacy impacts.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 13/11/2026, 22:46:19 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeigorhjekh6wix7n3s3cjl45frjukdfdmfdiwm5w3zcmhwygpzpeby